Radiotherapy Centre West, Lijnbaan 32, 2512 VA, The Hague, The Netherlands.
Strahlenther Onkol. 2012 Aug;188(8):696-701. doi: 10.1007/s00066-012-0122-3. Epub 2012 Jun 23.
The 1-year local control rates after single-fraction stereotactic radiotherapy (SRT) for brain metastases > 3 cm diameter are less than 70%, but with fractionated SRT (FSRT) higher local control rates have been reported. The purpose of this study was to compare our treatment results with SRT and FSRT for large brain metastases.
In two consecutive periods, 41 patients with 46 brain metastases received SRT with 1 fraction of 15 Gy, while 51 patients with 65 brain metastases received FSRT with 3 fractions of 8 Gy. We included patients with brain metastases with a planning target volume of > 13 cm(3) or metastases in the brainstem.
The minimum follow-up of patients still alive was 22 months. Comparing 1 fraction of 15 Gy with 3 fractions of 8 Gy, the 1-year rates of freedom from any local progression (54% and 61%, p = 0.93) and pseudo progression (85% and 75%, p = 0.25) were not significantly different. Overall survival rates were also not different.
The 1-year local progression and pseudo progression rates after 1 fraction of 15 Gy or 3 fractions of 8 Gy for large brain metastases and metastases in the brainstem are similar. For better local control rates, FSRT schemes with a higher biological equivalent dose may be necessary.
单次分割立体定向放疗(SRT)治疗直径>3cm 的脑转移瘤 1 年局部控制率小于 70%,但采用分割立体定向放疗(FSRT)可获得更高的局部控制率。本研究旨在比较 SRT 和 FSRT 治疗大体积脑转移瘤的结果。
在两个连续时期,41 例 46 个脑转移瘤患者接受单次 15Gy 分割 SRT,51 例 65 个脑转移瘤患者接受 3 次 8Gy 分割 FSRT。我们纳入了计划靶区体积>13cm³或脑干转移瘤患者。
仍存活患者的最短随访时间为 22 个月。比较 15Gy 单次分割与 8Gy 3 次分割,1 年无局部进展(54%和 61%,p=0.93)和假性进展(85%和 75%,p=0.25)的无进展率无显著差异。总生存率也无差异。
15Gy 单次分割或 8Gy 3 次分割治疗大体积脑转移瘤和脑干转移瘤 1 年后局部进展和假性进展的发生率相似。为了获得更好的局部控制率,可能需要采用更高生物等效剂量的 FSRT 方案。